Why Global Top‐Tier Teams Choose Chinese Research‐Reagent Brand?. Rigorous validation in metabolism, oncology immunology and gut‐brain‐axis research proves Cloud‐Clone antibodies' global‐competitive ...

Lund University. For most of his career as a researcher, Lars Björck has sought to understand how bacteria manage to evade ...

There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, including Alzheimer's disease, in which twisted clumps of a protein called ...

Treatment options for patients with relapsed/refractory follicular lymphoma have expanded rapidly. CD19-directed CAR T-cell therapies are approved in the third-line setting and beyond, and CD20 x CD3 ...

And what does it mean for the plant-based movement?

An autoinhibitory domain in the C-terminal tail of the TMEM63B, a mechanosensitive lipid scramblase, helps maintain its inactive state under resting ...

The structural adaptations follow the same logic. Top management identifies in clear and unambiguous terms the what: the ...

Being made redundant at 47 led to a fulfilling career pivot and saved me from a measly retirement fund ...

"Does it really matter to you if Google, OpenAI, Anthropic or any other company gets to open the AI floodgates first? Why can ...

AstraZeneca will put about $2 billion into Summit after the latter flagged in July that its cash pile was not enough to fund planned operations for a full year.

Summit Therapeutics Inc. (Nasdaq: SMMT) today announced key developments important to the company’s progress towards achieving its goal of making a significant difference in the lives of patients with ...